A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body
Clinical trial NCT01529684 · COMPLETED
Trial details
- NCT number
- NCT01529684
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-19
- Primary completion
- 2012-12-08
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.